About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

SUSPENDEDNANCT05689710

The Effects of Inositol on Glucose Metabolism in Patients With Metabolic Syndrome at Risk of Cardiac Fibrosis

The study aims to evaluate the effects of an oral supplementation based on inositols and alpha-lactalbumin on principals metabolic parameters in patients with metabolic syndrome at risk of cardiac fib...

Lead sponsor: Lo.Li.Pharma s.r.l•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

Lo.Li.Pharma s.r.l

Age

All ages

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•triglycerides levels ≥ 150 mg/dL
•HDL ≤ 40 mg/dL
•Fasting glycemia \> 100 mg/dL \<126 mg/dl
•Systolic Pressure ≥ 130 mmHg or Diastolic pressure ≥ 85 mmHg
•Hip circumference \> 102 cm in men or 88 cm in women

Related studies

The Mom and Infant Outcomes (MOMI) Study

NCT06277661 · Postpartum Depression, Postpartum Anxiety, and more

Study on Construction of Whole Lifecycle Cohort, Big Data Management and Clinical Prognosis of Cardio-Renal-Metabolic (CKM) Syndrome

NCT07547098 · Cardiovascular Diseases (CVD), Chronic Kidney Disease, and more

Rutazyme Lemon Fermented Product Capsules for Metabolic Function in Adults With Obesity

NCT07540949 · Obesity, Metabolic Syndrome

Spinal Cord Injury Model Systems (SCIMS) - Education Module

NCT06003686 · Spinal Cord Injuries, Obesity, and more

A Study Of Milk Consumption In Metabolic Syndrome

NCT07401888 · Metabolic Syndrome

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: December 30, 2025Terms

Trial snapshot

StatusSUSPENDED

PhaseNA

Enrollment30

Start dateDec 2022

Last updatedDec 30, 2025

Condition

Metabolic Syndrome Cardiac Fibrosis

Locations shown

UOC Medicina Interna e Nefrologia P.O. AQ

L’Aquila

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: December 30, 2025Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions